CVE-2016-8344

Description

An issue was discovered in Honeywell Experion Process Knowledge System (PKS) platform: Experion PKS, Release 3xx and prior, Experion PKS, Release 400, Experion PKS, Release 410, Experion PKS, Release 430, and Experion PKS, Release 431. Experion PKS does not properly validate input. By sending a specially crafted packet, an attacker could cause the process to terminate. A successful exploit would prevent firmware uploads to the Series-C devices.

Category

3.7
CVSS
Severity: Low
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.94% Top 25%
Third-Party Advisory securityfocus.com Third-Party Advisory us-cert.gov
Affected: n/a Honeywell Experion PKS through 431
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSA-16-301-01 mitigation third party advisory us government resource
http://www.securityfocus.com/bid/93950 third party advisory vdb entry

Frequently Asked Questions

What is the severity of CVE-2016-8344?
CVE-2016-8344 has been scored as a low severity vulnerability.
How to fix CVE-2016-8344?
To fix CVE-2016-8344, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2016-8344 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2016-8344 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2016-8344?
CVE-2016-8344 affects n/a Honeywell Experion PKS through 431.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.